Sai Parenterals to buy majority stake in Bion Therapeutics
Bion will become a step-down subsidiary of SAI Parenterals on completion of the deal, which is expected before the end of this month in an all-cash deal.
Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].

